Literature DB >> 16376987

Defining the role of gene regulation in resistance to HDAC inhibitors--mechanisms beyond P-glycoprotein.

Keith B Glaser.   

Abstract

The manuscript by Yamada et al. "Depsipeptide-resistant KU812 cells show reversible P-glycoprotein expression, hyperacetylated histones, and modulated gene expression profile," describes not only development of the major resistance mechanism, P-glycoprotein expression, but how histone deacetylase inhibitors can modulate the gene expression profile to promote survival and resistance to depsipeptide.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16376987     DOI: 10.1016/j.leukres.2005.10.016

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  3 in total

1.  HDAC inhibitor-induced drug resistance involving ATP-binding cassette transporters (Review).

Authors:  Xuan Ni; Li Li; Guoyu Pan
Journal:  Oncol Lett       Date:  2014-11-19       Impact factor: 2.967

2.  Combinatorial Antitumor Activity of Oxaliplatin with Epigenetic Modifying Agents, 5-Aza-CdR and FK228, in Human Gastric Cancer Cells.

Authors:  Jong Kook Park; Jung Seon Seo; Suk Kyeong Lee; Kenneth K Chan; Hyo-Jeong Kuh
Journal:  Biomol Ther (Seoul)       Date:  2018-11-01       Impact factor: 4.634

3.  The Selective Class IIa Histone Deacetylase Inhibitor TMP195 Resensitizes ABCB1- and ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs.

Authors:  Chung-Pu Wu; Sabrina Lusvarghi; Jyun-Cheng Wang; Sung-Han Hsiao; Yang-Hui Huang; Tai-Ho Hung; Suresh V Ambudkar
Journal:  Int J Mol Sci       Date:  2019-12-29       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.